Greenland Mines LtdG
Greenland Mines Ltd (Nasdaq: GRML, CIK 0001907223) combines three businesses after a reverse merger. The Biotech division is active but impaired (a US$2.05M Q1 2026 write-down of generic-drug licenses) and carries explicit going-concern language in the Jun 2026 10-Q. Two mining assets: (1) Skaergaard, SE Greenland -- an 80% GRML / 20% Intrusion Precious Metals Corp JV, one of the largest undeveloped PGM deposits in the western world, with an S-K 1300 Technical Report Summary (SLR Consulting Canada Ltd, eff. 3 Jul 2026), no economic study yet; (2) Sarfartoq, SW Greenland -- 100% owned via the acquisition, completed 2 Sep 2026, of Neo North Star Resources Inc. (US$35M: $20M cash + $15M GRML stock, definitive agreement 20 May 2026); Neo Performance Materials (TSX: NEO) holds only an offtake right on up to 60% of future production, not an equity stake. Sarfartoq carries a completed SEC S-K 1300-compliant Initial Assessment (the PEA-equivalent standard), making it the more advanced of the two mining projects.
Notable vs. Peers
- Jurisdiction risk score of 6/10 is meaningfully riskier than the peer average of 7.7/10.
Lifecycle Milestones
Jurisdiction (40%)6/10
Greenland (an autonomous territory of the Kingdom of Denmark) is stable under Danish rule of law but carries real, demonstrated jurisdiction-specific mining-political risk: a 2021 law banning exploration/mining of deposits over 100ppm uranium concentration effectively killed the Kvanefjeld rare-earth project (Energy Transition Minerals), and only 2 commercial mines operate on the entire island as of mid-2026. Set against this, Greenland's 2025-2029 Mineral Resources Strategy is actively easing permitting/tax terms for non-uranium critical-minerals projects (molybdenum, graphite, REE). Neither Skaergaard (PGM) nor Sarfartoq (Nd-Pr, no material uranium byproduct disclosed) is directly implicated by the uranium ban, but the demonstrated willingness to reject/reverse mining licenses on political grounds is real and not captured by a reflexive Tier-1 Canada/Australia score.
Infrastructure (40%)No verified figure
Researched with nothing found: no source we could cite confirms or rules out an existing mill, road access, grid power, or tailings facility at Sarfartoq Neodymium-Praseodymium Rare Earth Project, Southwest Greenland (checked Sep 26, 2026; recheck due Mar 25, 2027). Counts at a neutral 5/10 until one does.
Nearby producing mine (20%)Not yet researched
No project coordinates on file yet, so distance to a producing mine can't be measured.
Acquisition Susceptibility
A relative ranking of how closely this company matches the profile of juniors that have actually been acquired — not a probability, and not a reason to buy. Acquisitions are rare: only a few dozen significant deals happen a year across a universe of thousands of juniors, so even a high score here describes a long shot. The strongest signal in the research, a producer that already owns part of the company, is scored from its disclosed strategic shareholders. A producer that is a joint-venture or earn-in partner on the project, rather than a shareholder, isn't captured yet.
How this score is built
- Disclosed pending dealSub-score: Not scored
A disclosed corporate action (not an acquisition or merger)
A corporate action of this kind says nothing about takeover susceptibility, so it isn't scored.
Weight 26.25% - Producer's strategic stakeSub-score: Not scored
No producer holds a disclosed stake on file (holder register researched) See holders
Not scored: most juniors that do get bought had no prior toehold, so a missing stake says little either way.
Weight 25% - Distance to a producing mineSub-score: Not yet researched
Distance not yet researched: no project coordinates on file
Distance can't be measured without coordinates, so excluded rather than counted as far.
Weight 22.5% - Lifecycle stageSub-score:6/10
Stage: Preliminary Economic Assessment
Feasibility and permitting score 10, where deals cluster, and production 5.5; earlier stages score less, down to 1 at grassroots.
Weight 15% · 57% here - JurisdictionSub-score:6/10
Greenland: jurisdiction score 6/10
Our jurisdiction score, used as is: higher means lower political and permitting risk.
Weight 6.75% · 26% here - CommoditySub-score:2/10
Primary commodity: Other
Gold 10, copper 8, silver 5, nickel and uranium 4, others 2: most majors' deals are for gold.
Weight 4.5% · 17% here
Weight is each input's share of the full score. “Here” is its share of this company's score: inputs that aren't scored are left out and the rest re-weighted, never counted as zero.
Your Rankings
Management Team
President of Greenland Mines Ltd. A seasoned executive with over 20 years in mineral exploration and natural resource development across Europe and the Arctic. Holds a PhD in economic geology and previously held a role at the Geological Survey of Denmark and Greenland (GEUS). Source: greenlandmines.com/about/.
Chief Financial Officer of Greenland Mines Ltd. Over 20 years of experience managing financial operations, investing, and advising Fortune 500 companies. Co-founded Winvest Acquisition Corp; prior roles at McKinsey, Greenlight Capital and GE Capital. Source: greenlandmines.com/about/.
Vice President, Exploration of Greenland Mines Ltd. A geologist with more than 25 years of global exploration experience, including previous roles at Sayona Mining and Exeter Resource. Source: greenlandmines.com/about/.
Country Manager, Logistics & Studies for Greenland Mines Ltd. Over 30 years of hands-on experience living and working in Greenland, specialising in operational, logistical and facility management. Source: greenlandmines.com/about/.
Permitting & Community Manager for Greenland Mines Ltd. A Greenlandic executive based in Nuuk with expertise in government liaison, regulatory engagement, and health & safety. Source: greenlandmines.com/about/.
Independent Director of Greenland Mines Ltd. Holds a PhD in Complex Analysis and was a mathematics professor; later served as Chief Financial Officer and then Chief Executive Officer of Manhattan Textile Corporation. Board experience across multiple technology and medical startups. Currently chairs the Audit Committee at Acorn Energy and chairs several education-focused nonprofit boards. Source: ir.greenlandmines.com board of directors page.
Independent Director of Greenland Mines Ltd. President & CEO of EthiX Associates, a healthcare consultancy he founded in 1996. Co-founded NeuroEM Therapeutics and serves as an Advisor to Arizona State University's Biodesign Institute. Has launched over 40 products and held senior positions at GlaxoSmithKline, Bristol Myers Squibb and Novartis. Source: ir.greenlandmines.com board of directors page.
Director of Greenland Mines Ltd. (Nasdaq: GRML), appointed effective 8 September 2026 to fill a Board vacancy, to serve until the company's next annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier resignation or removal.
Founder, Chief Executive Officer, Director and Chairman of the Board of Greenland Mines Ltd. (Nasdaq: GRML), the company formerly known as Klotho Neurosciences, Inc. Over 40 years of drug, biologic and medical device R&D and commercialization experience, having personally managed more than 8 drug and biotech products through FDA approval to market, plus 5 medical devices and 8 in vitro diagnostics. Serves on multiple boards and consults for venture capital firms and pharmaceutical companies. Confirmed as CEO by his signature on the company's 8-K filed 11 September 2026. Sources: greenlandmines.com/about/, ir.greenlandmines.com board page, and SEC 8-K.
Insiders, Investors & Smart Money
Notable shareholders and insiders whose involvement is worth knowing about, plus what we're seeing from institutional/large-investor activity.
No smart-money tracking (institutional/large-investor activity) for this miner yet — this is a planned feature, not live data.
No notable insiders tracked for this miner yet.
Reports, Presentations & Documents
Greenland Mines, formerly Klotho Neurosciences, became a mining company through a reverse merger with Greenland Mines Corp on 4 March 2026 and plans to spin off its remaining biotechnology division, which is developing an ALS gene therapy, in the fourth quarter of 2026. Its most advanced asset is the 100%-owned Sarfartoq neodymium-praseodymium rare earth project in south-west Greenland, acquired in September 2026 for US$35M in cash and shares, where Neo Performance Materials holds an offtake right on up to 60% of future production. Sarfartoq's resource, effective 31 July 2026, contains 110,400 t of total rare earth oxides in the indicated category (6.9 Mt at 1.60%), with no measured category, plus 5.3 Mt at 0.96% inferred, and its Initial Assessment outlines a 9-year mine life processing 1.4 Mtpa, although only a high-case sensitivity of its economics has been disclosed. The company also holds 80% of the Skaergaard palladium-gold-platinum project in south-east Greenland, which has a technical report summary but no economic study yet.